BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2016 10:34:00 AM | Browse: 521 | Download: 799
Publication Name World Journal of Hepatology
Manuscript ID 23873
Country of Manuscript Source Thailand
Received
2015-12-22 09:30
Peer-Review Started
2015-12-22 15:20
To Make the First Decision
2016-01-20 16:37
Return for Revision
2016-01-21 16:05
Revised
2016-02-22 18:26
Second Decision
2016-03-07 15:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-03-16 16:06
Articles in Press
2016-03-16 16:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-03-21 10:09
Publish the Manuscript Online
2016-03-24 10:34
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Systematic Review
Article Title Comprehensive review of telbivudine in pregnant women with chronic hepatitis B
Manuscript Source Invited Manuscript
All Author List Teerha Piratvisuth, Guo Rong Han, Stanislas Pol, Yuhong Dong and Aldo Trylesinski
Funding Agency and Grant Number
Funding Agency Grant Number
Novartis Pharma AG
Corresponding author Dr. Teerha Piratvisuth, MD, Department of Medicine, NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University, 15 Equipment Acantholysis SOI Road, Hat Yai District, Songkhla 90110, Thailand. teerha.p@psu.ac.th
Keywords Telbivudine; Hepatitis B virus; Pregnancy; Mother-to-child transmission; Vertical transmission
Core Tip The data from literatures, pharmacovigilance reports on telbivudine exposure and antiretroviral pregnancy registry during pregnancy in women with hepatitis B virus (HBV) infection showed no increased rates of live birth defects, spontaneous abortion or elective termination. No fetal/neonatal toxicity was reported during telbivudine treatment. Telbivudine exposure in the second and/or third trimesters of pre-gnancy has been shown to reduce the risk of HBV trans-mission from mother to child if administered in addition to hepatitis B immunoglobulin and HBV vaccination with a favorable safety profile.
Publish Date 2016-03-24 10:34
Citation Piratvisuth T, Han GR, Pol S, Dong Y, Trylesinski A. Compre­hensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol 2016; 8(9): 452-460
Url http://www.wjgnet.com/1948-5182/full/v8/i9/452.htm
DOI http://dx.doi.org/10.4254/wjh.v8.i9.452
Full Article (PDF) WJH-8-452.pdf
Full Article (Word) WJH-8-452.doc
Manuscript File 23873-Review.docx
Answering Reviewers 23873-Answering reviewers.pdf
Audio Core Tip 23873-Audio core tip.MP3
Conflict-of-Interest Disclosure Form 23873-Conflict-of-interest statement.pdf
Copyright License Agreement 23873-Copyright assignment.pdf
Peer-review Report 23873-Peer-review(s).pdf
Scientific Misconduct Check 23873-Scientific misconduct check.pdf
Scientific Editor Work List 23873-Scientific editor work list.pdf